These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7875951)

  • 41. Abnormalities of serotonergic neurotransmission in animal models of SUDEP.
    Feng HJ; Faingold CL
    Epilepsy Behav; 2017 Jun; 71(Pt B):174-180. PubMed ID: 26272185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.
    Nguyen KQ; Tohyama Y; Watanabe A; Hasegawa S; Skelin I; Diksic M
    Neurochem Int; 2009; 54(3-4):161-71. PubMed ID: 19073228
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suicidality, circadian activity rhythms and platelet serotonergic measures in patients with recurrent suicidal behaviour.
    Verkes RJ; Kerkhof GA; Beld E; Hengeveld MW; van Kempen GM
    Acta Psychiatr Scand; 1996 Jan; 93(1):27-34. PubMed ID: 8919326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Psychobiology of suicide].
    Linnoïla M
    Encephale; 1996 Dec; 22 Spec No 4():10-4. PubMed ID: 9138929
    [No Abstract]   [Full Text] [Related]  

  • 47. Fluoxetine: a suitable long-term treatment.
    Calil HM
    J Clin Psychiatry; 2001; 62 Suppl 22():24-9. PubMed ID: 11599644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects.
    Leon AC; Keller MB; Warshaw MG; Mueller TI; Solomon DA; Coryell W; Endicott J
    Am J Psychiatry; 1999 Feb; 156(2):195-201. PubMed ID: 9989554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacology of rapid-onset antidepressant treatment strategies.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Akathisia, suicidality, and fluoxetine.
    Hamilton MS; Opler LA
    J Clin Psychiatry; 1992 Nov; 53(11):401-6. PubMed ID: 1364815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].
    Le Poul E; Lima L; Laporte AM; Even C; Doucet E; Fattaccini CM; Laaris N; Hamon M; Lanfumey L
    Encephale; 1995; 21(2):123-32. PubMed ID: 7781583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neonatal fluoxetine exposure modulates serotonergic neurotransmission and disturb inhibitory action of serotonin on food intake.
    Pinheiro IL; da Silva AI; Reginato A; da Silva Filho RC; Galindo LCM; Matos RJB; de Souza Ferraz JC; Toscano Meneses da Silva Castro AE; Milanski Ferreira M; Manhães de Castro R; de Souza SL
    Behav Brain Res; 2019 Jan; 357-358():65-70. PubMed ID: 28756214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Bailly D
    Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does treatment with antidepressant medication increase suicidal behavior?
    Goldblatt MJ; Schatzberg AF
    Int Clin Psychopharmacol; 1991; 6(4):219-26. PubMed ID: 1816279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
    KoKoAung E; Cavenett S; McArthur A; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of increased serotonergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies.
    Carrillo M; Ricci LA; Coppersmith GA; Melloni RH
    Psychopharmacology (Berl); 2009 Aug; 205(3):349-68. PubMed ID: 19404614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suicidality with selective serotonin reuptake inhibitors: Valid claim?
    Lapierre YD
    J Psychiatry Neurosci; 2003 Sep; 28(5):340-7. PubMed ID: 14517577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
    Healy D
    Psychother Psychosom; 2003; 72(2):71-9. PubMed ID: 12601224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder.
    Phillips KA; Kelly MM
    Int Clin Psychopharmacol; 2009 Jan; 24(1):26-8. PubMed ID: 19060721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
    Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.